Arkis BioSciences develops advanced treatments for intracranial hypertension, including hydrocephalus and other related disorders, ranging from surgical tools to state of the art implantables. Founded in 2011 by a neurosurgeon, former engineering patent examiner, and business developer, Arkis began development of a portfolio of products that results in safer and less invasive surgeries as well as improved shunt options to result in personalized treatments for a leap in patient outcomes.
| Website | http://www.arkisbiosciences.com |
| Revenue | $3 million |
| Funding | $3.4 million |
| Employees | 10 (0 on RocketReach) |
| Founded | 2011 |
| Address | 1 Momentum Way, Knoxville, Tennessee 37920, US |
| Phone | (844) 247-5383 |
| Technologies |
JavaScript
,
HTML
,
Microsoft Outlook
+3 more
(view full list)
|
| Industry | Biotechnology, Medical Devices & Equipment, Manufacturing, Science and Engineering, Health Care, Medical Device |
| Web Rank | 32 Million |
| Keywords | Medical Innovation, Surgical Innovation, Neurosurgical Devices, Implantable Medical Devices, Surgical Tools, Brain Surgery, Medical Implants, Advanced Therapies, Neurological Disorders, Minimally Invasive Neurosurgery, Medical Technology, Biomedical Devices, Healthcare Technology |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Merck Group, Bio-Rad Laboratories, QIAGEN, New England Biolabs, Clontech Laboratories, Inc. +44 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
Looking for a particular Arkis BioSciences employee's phone or email?
The Arkis BioSciences annual revenue was $3 million in 2026.
Arkis BioSciences is based in Knoxville, Tennessee.
The SIC codes for Arkis BioSciences are [384, 38].